- Release Date: 13/10/22 09:47
- Summary: Positive BTX 1702 Phase 1b/2 Clinical Study for Rosacea
- Price Sensitive: Yes
- Download Document 5.36MB
Ann: Positive BTX 1702 Phase 1b/2 Clinical Study for Rosacea
- There are more pages in this discussion • 100 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
22.5¢ |
Change
0.005(2.27%) |
Mkt cap ! $346.5M | |||
| Open | High | Low | Value | Volume |
| 21.5¢ | 22.5¢ | 21.5¢ | $539.3K | 2.440M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 421699 | 22.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.0¢ | 366832 | 10 |
View Market Depth
| Last trade - 13.24pm 01/05/2024 (20 minute delay) ? |
|
|||||
|
Last
22.5¢ |
Change
0.005 ( 3.45 %) |
||||
| Open | High | Low | Volume | ||
| 21.8¢ | 22.5¢ | 21.5¢ | 647076 | ||
| Last updated 13.46pm 01/05/2024 ? | |||||
| BOT (ASX) Chart |